肾动脉狭窄血运重建的治疗现状及发展趋势
孟雅琪， 刘艳阳， 田海萍， 李婷 - 中国全科医学, 2023 - chinagp.net
… A mitochondrial permeability transition pore inhibitor improves renal outcomes after
revascularization … growth factor improves renal outcomes following revascularization[J]. Am J …
revascularization … growth factor improves renal outcomes following revascularization[J]. Am J …
[PDF][PDF] 线粒体通透性转换孔与急性肾损伤
宣小燕， 张爱华， 黄松明 - 中华肾脏病杂志, 2015 - cjn.org.cn
… A mitochondrial permeability transition pore inhibitor improves renal outcomes after
revascularization in experimental atherosclerotic renal artery stenosis[J]. Hypertension, 2012, 60(5): …
revascularization in experimental atherosclerotic renal artery stenosis[J]. Hypertension, 2012, 60(5): …
红细胞生成素对神经退变和缺血性疾病的神经保护作用: EpoR 的功效
CC Hernández, CF Burgos, AH Gajardo… - 中国神经再生研究 …, 2017 - sjzsyj.com.cn
… with chronic renal failure and renal failure associated with … were modified to improve stability
and to increase its half-life, … with an inhibition of mitochondrial permeability transition pore …
and to increase its half-life, … with an inhibition of mitochondrial permeability transition pore …
引人注目的血管内皮生长因子: 缺氧缺血性脑损伤干预靶点
H Guo, H Zhou, J Lu, Y Qu, D Yu, Y Tong - 中国神经再生研究(英文版), 2016 - sjzsyj.com.cn
… 2-associated death promoter, which increases the removal of Bcl-xL from mitochondria,
blocks the formation of the mitochondrial permeability transition pore, and maintains the mitochon…
blocks the formation of the mitochondrial permeability transition pore, and maintains the mitochon…
[PDF][PDF] 线粒体靶向治疗在慢性肾脏病中的研究进展
朱赛雅， 牛阳阳， 余晨 - 中华肾脏病杂志, 2021 - cjn.org.cn
… A mitochondrial permeability transition pore inhibitor improves renal outcomes after
revascularization in experimental atherosclerotic renal artery stenosis[J]. Hypertension, 2012, 60(5): …
revascularization in experimental atherosclerotic renal artery stenosis[J]. Hypertension, 2012, 60(5): …